Hematology NewsFDA approves turoctocog alfa pegol for hemophilia AFebruary 20, 2019Bleeding Disorders
Hematology NewsNovel FVIII biomarker could help tailor hemophilia treatmentFebruary 14, 2019Bleeding Disorders
Hematology NewsInhibitor risk nears zero after 75 days in previously untreated hemophilia AFebruary 13, 2019Bleeding DisordersPediatrics
Hematology NewsTranexamic acid shows improvements in heavy menstrual bleedingFebruary 13, 2019PediatricsBleeding Disorders
Hematology NewsMeta-analysis: IVIG bests anti-D on platelet count in pediatric ITPFebruary 5, 2019Bleeding DisordersRare DiseasesPediatrics
Hematology NewsTuroctocog alfa appears safe, effective in reducing bleedsJanuary 30, 2019Bleeding Disorders
Hematology NewsThrombin generation looks promising as a hemophilia biomarkerJanuary 30, 2019Bleeding Disorders
Hematology NewsStudy identifies four patient subgroups in hemophilia AJanuary 29, 2019Bleeding Disorders
Hematology NewsImpaired clot lysis associated with mild bleeding symptomsJanuary 27, 2019ThrombosisMixed TopicsBleeding Disorders
Hematology NewsInvestigational gene therapy shows promise in hemophilia AJanuary 18, 2019Bleeding DisordersGene Therapy
Hematology NewsRNA expression may hold key to hemophilia A severityJanuary 17, 2019Bleeding Disorders
Hematology NewsNew guidance: Preventing steroid-induced osteoporosis in ITPJanuary 16, 2019Bleeding Disorders
